Statistics for Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status
Total visits
| views | |
|---|---|
| Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status | 134 |
Total visits per month
| views | |
|---|---|
| November 2024 | 7 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Rev Port Pneumol.pdf(legacy) | 242 |
| Rev Port Pneumol.pdf | 13 |
Top country views
| views | |
|---|---|
| United States | 80 |
| China | 29 |
| Canada | 8 |
| Australia | 7 |
| India | 4 |
| Argentina | 1 |
| France | 1 |
| Japan | 1 |
| Mongolia | 1 |
| Portugal | 1 |